NUVA * Stock Overview
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
NuVasive, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1,079.09 |
| 52 Week High | US$1,147.67 |
| 52 Week Low | US$999.33 |
| Beta | 1.07 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 9.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| NUVA * | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how NUVA * performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how NUVA * performed against the MX Market.
Price Volatility
| NUVA * volatility | |
|---|---|
| NUVA * Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: NUVA * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NUVA *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 3,000 | Chris Barry | www.nuvasive.com |
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room.
NuVasive, Inc. Fundamentals Summary
| NUVA * fundamental statistics | |
|---|---|
| Market cap | Mex$40.26b |
| Earnings (TTM) | Mex$729.17m |
| Revenue (TTM) | Mex$21.69b |
55.2x
P/E Ratio1.9x
P/S RatioIs NUVA * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NUVA * income statement (TTM) | |
|---|---|
| Revenue | US$1.20b |
| Cost of Revenue | US$336.51m |
| Gross Profit | US$865.44m |
| Other Expenses | US$825.03m |
| Earnings | US$40.41m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.77 |
| Gross Margin | 72.00% |
| Net Profit Margin | 3.36% |
| Debt/Equity Ratio | 102.7% |
How did NUVA * perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/04/28 17:56 |
| End of Day Share Price | 2023/01/29 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NuVasive, Inc. is covered by 41 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Wittes | Aegis Capital Corporation |
| null null | Argus Research Company |
| Jeffrey Johnson | Baird |